Flatiron Health pioneers real-world evidence for oncology, extracting actionable insights from the experiences of cancer patients to inform treatment decisions and accelerate research. As an independent affiliate of the Roche Group since 2018, the company operates at the intersection of clinical medicine, data science, and software engineering, partnering with hundreds of community cancer centers and major academic institutions across the United States, Europe, and Asia.
The company's technical foundation rests on machine learning and artificial intelligence applied to oncology data, enabling the transformation of patient experiences into evidence that modernises the cancer care ecosystem. Flatiron's work spans real-world evidence generation, clinical trial optimisation, and the development of AI-driven solutions that serve both treatment providers and researchers seeking to improve outcomes at scale.
Teams at Flatiron comprise oncologists, data scientists, software engineers, epidemiologists, and product specialists working in concert toward a shared mission. The company maintains offices in Germany, the United Kingdom, and Japan, reflecting its commitment to advancing cancer care across multiple geographies and healthcare systems.
